475 related articles for article (PubMed ID: 25186187)
1. Kidney: polycystic kidney disease.
Paul BM; Vanden Heuvel GB
Wiley Interdiscip Rev Dev Biol; 2014; 3(6):465-87. PubMed ID: 25186187
[TBL] [Abstract][Full Text] [Related]
2. Polycystic kidney disease: new understanding in the pathogenesis.
Wilson PD
Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
[TBL] [Abstract][Full Text] [Related]
3. The exocyst protein Sec10 interacts with Polycystin-2 and knockdown causes PKD-phenotypes.
Fogelgren B; Lin SY; Zuo X; Jaffe KM; Park KM; Reichert RJ; Bell PD; Burdine RD; Lipschutz JH
PLoS Genet; 2011 Apr; 7(4):e1001361. PubMed ID: 21490950
[TBL] [Abstract][Full Text] [Related]
4. The genetics and physiology of polycystic kidney disease.
Calvet JP; Grantham JJ
Semin Nephrol; 2001 Mar; 21(2):107-23. PubMed ID: 11245774
[TBL] [Abstract][Full Text] [Related]
5. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
Kurbegovic A; Trudel M
Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
[TBL] [Abstract][Full Text] [Related]
7. NHA2 promotes cyst development in an in vitro model of polycystic kidney disease.
Prasad H; Dang DK; Kondapalli KC; Natarajan N; Cebotaru V; Rao R
J Physiol; 2019 Jan; 597(2):499-519. PubMed ID: 30242840
[TBL] [Abstract][Full Text] [Related]
8. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease.
Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of polycystic kidney disease.
Calvet JP
J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
[TBL] [Abstract][Full Text] [Related]
10. Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.
Parker MI; Nikonova AS; Sun D; Golemis EA
Cell Signal; 2020 Mar; 67():109497. PubMed ID: 31830556
[TBL] [Abstract][Full Text] [Related]
11. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
Lantinga-van Leeuwen IS; Dauwerse JG; Baelde HJ; Leonhard WN; van de Wal A; Ward CJ; Verbeek S; Deruiter MC; Breuning MH; de Heer E; Peters DJ
Hum Mol Genet; 2004 Dec; 13(24):3069-77. PubMed ID: 15496422
[TBL] [Abstract][Full Text] [Related]
12. Polycystic kidney disease: etiology, pathogenesis, and treatment.
Martinez JR; Grantham JJ
Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
[TBL] [Abstract][Full Text] [Related]
13. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
Kurbegovic A; Trudel M
Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
Sessa A; Ghiggeri GM; Turco AE
J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
[TBL] [Abstract][Full Text] [Related]
15. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.
Bukanov NO; Smith LA; Klinger KW; Ledbetter SR; Ibraghimov-Beskrovnaya O
Nature; 2006 Dec; 444(7121):949-52. PubMed ID: 17122773
[TBL] [Abstract][Full Text] [Related]
16. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
[TBL] [Abstract][Full Text] [Related]
17. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.
Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA
Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569
[TBL] [Abstract][Full Text] [Related]
18. Polycystic kidney disease in Sprague-Dawley rats.
Shoieb A; Shirai N
Exp Toxicol Pathol; 2015; 67(5-6):361-4. PubMed ID: 25753522
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease.
Idowu J; Home T; Patel N; Magenheimer B; Tran PV; Maser RL; Ward CJ; Calvet JP; Wallace DP; Sharma M
Sci Rep; 2018 Feb; 8(1):3340. PubMed ID: 29463793
[TBL] [Abstract][Full Text] [Related]
20. Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.
Alcalay NI; Sharma M; Vassmer D; Chapman B; Paul B; Zhou J; Brantley JG; Wallace DP; Maser RL; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1725-34. PubMed ID: 18829740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
